Simoons Ml

2.3k citations
30 papers · 310 indexed · h-index 6

Impact in

Papers in

    • Venous Thromboembolism Diagnosis and Management 3
    • Acute Myocardial Infarction Research 6
    • Antiplatelet Therapy and Cardiovascular Diseases 4
    • Cardiovascular Function and Risk Factors 3
    • Heart Failure Treatment and Management 2

Simoons Ml

24 papers receiving 289 citations

Peers

Simoons Ml
Comparison fields: 5 of 53
  • Internal Medicine 79
  • Cardiology and Cardiovascular Medicine 223
  • Transplantation 7
  • Radiology, Nuclear Medicine and Imaging 59
  • Epidemiology 77
Replace Peter Braidley with:
Peter Braidley United Kingdom
Moshe Halak Israel
Dennis Zavalloni Italy
Jürgen Falkensammer Austria
Parul Rathor China
Saurabh Sanon United States
John A. Carey United States
Mustafa Ozan Gürsoy Türkiye
William R. Maddox United States
Robert D. Riley United States
Simoons Ml relative to Peter Braidley United Kingdom Peter Braidley's profile →
Citations per field
00.5×3.8×
Peter Braidley · 1×
Citations per year

Countries citing papers authored by Simoons Ml

Since Specialization
Citations

This map shows the geographic impact of Simoons Ml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simoons Ml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simoons Ml more than expected).

Fields of papers citing papers by Simoons Ml

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simoons Ml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simoons Ml. The network helps show where Simoons Ml may publish in the future.

Co-authors

The 25 scholars most cited alongside Simoons Ml, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simoons Ml Line = papers co-authored together Simoons Ml links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1993194
2
Coronary artery disease after heart transplantation: timing of coronary arteriography.
199328
3 201322
4
Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications.
199813
5
EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease.
19988
6
Intracranial hemorrhage after thrombolytic therapy. A perspective.
19935
7
Prognostic significance of nonfatal myocardial reinfarction in survivors of a first infarction.
20015
8
Cytoimmunological monitoring to detect rejection after heart transplantation.
19894
9
[Twelve year triage and thrombolysis treatment prior to hospitalization for myocardial infarction patients in the Rotterdam area of the Netherlands: outstanding short-term and long-term results].
20014
10
Role of echocardiography in the diagnosis and management of infective endocarditis.
20044
11 20093
12
Ridogrel as adjunct to thrombolysis in acute myocardial infarction
19922
13
Complete coronary perfusion (TIMI flow 3) improves prognosis after myocardial infarction but not incomplete (TIMI 2) perfusion
19932
14
The Survival Advantage of Early Complete Reperfusion (TIMI Grade 3) After Infarction Doubles Between 30 Days and 2 Years
19952
15
Mortality reduction with accelerated tissue plasminogen activator is explained by early coronary patency
19932
16
[Earlier treatment of acute myocardial infarction with administration of alteplase (rt-PA) before hospitalization].
19902
17
Intravenous rt-PA for acute myocardial infarction: which patients benefit most?
19881
18
Risk assessment and longterm survival after thrombolytic therapy
19931
19
Frequency, Patient Characteristics, and Outcomes of Mild to Moderate Heart Failure Complicating ST-Segment Elevation Acute Myocardial Infarction: Lessons from Four International Fibrinolytic Therapy Trials
20011
20
Extra myoglobin peaks corroborate the diagnosis of stuttering infarction
19931

About Simoons Ml

Simoons Ml is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Transplantation, Surgery and Epidemiology, having authored 30 papers that have together received 310 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (6 papers), Acute Ischemic Stroke Management (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Cardiac Imaging and Diagnostics (4 papers), Transplantation: Methods and Outcomes (3 papers), Cardiovascular Function and Risk Factors (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Heart Failure Treatment and Management (2 papers). The work is most often cited by research in Internal Medicine (79 citations), Cardiology and Cardiovascular Medicine (223 citations), Transplantation (7 citations), Radiology, Nuclear Medicine and Imaging (59 citations) and Epidemiology (77 citations). Simoons Ml has collaborated with scholars based in Netherlands, Italy and Germany. Frequent co-authors include Eugene Braunwald, Aldo P. Maggioni, Ron van Domburg, Eric Boersma, Genell L. Knatterud, Peter de Jaegere, Robert M. Califf, Bos E, B. Mochtar and Willem Weimar. Their work appears in journals such as Circulation, Critical Care, European Heart Journal, Journal of the American College of Cardiology and European Heart Journal Acute Cardiovascular Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026